Ber Gerard
- SEC CIK
- 0001762144
No open-market purchases or sales filed in the past year.
Current role at each company
- LNTH Lantheus Holdings, Inc.Directoras of Jun 3, 2026
- YMAB Y-mAbs Therapeutics, Inc.Directoras of Jun 11, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Ber Gerard as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
LNTH Lantheus Holdings, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 14, 2024 (view filing) | Aug 12 | 2 days | Ber GerardDirector | SSale | −15.5K | $96.48 | −$1.50M | −42.2%21.2K after | 3 lots10b5-1 |
| May 12, 2022 (view filing) | May 10 | 2 days | Ber GerardDirector | SSale | −1.28K | $58.19 | −$74.3K | −3.8%32.7K after |
YMAB Y-mAbs Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 11, 2024 (view filing) | Jun 10 | 1 day | Ber GerardDirector | SSale | −722 | $12.00 | −$8.66K | −31.0%1.61K after |